On Friday, President Biden announced the Advanced Pharmaceutical Manufacturing (APM) Cluster as one of 21 winners of the $1 billion Build Back Better Regional Challenge, the American Rescue Plan administered by the US Department of Commerce’s Economic Development Administration (EDA). The Regional Challenge is awarding approximately $52.9 million in grants to the Advanced Pharmaceutical Manufacturing (APM) Cluster, led by the Virginia Biotechnology Research Partnership Authority (Activation Capital), to boost Virginia’s pharmaceutical industry.
With $52.9 million in funding from EDA, the Advanced Pharmaceutical Manufacturing (APM) Cluster will expand the domestic supply chain for essential medicines and critical active pharmaceutical ingredients (APIs). The projects funded as part of this award include expanding a nascent pharmaceutical manufacturing corridor in Central Virginia through investment in new wet lab space, development of critical infrastructure to sustain industrial capacity in Petersburg, and engagement with local business to enhance the regional pharmaceutical supply chain. The project will also catalyze a new partnership between Virginia Commonwealth University and Virginia State University to create new pathways for underserved residents to high-quality training and jobs in the pharmaceutical industry.
The Advanced Pharmaceutical Manufacturing (APM) Cluster is one of 21 winners—each a regional coalition of partnering entities—that will receive awards between $25 million and $65 million to implement an average of six integrative projects that will enable each region's economic transformation and competitiveness.
The Build Back Better Regional Challenge's other winner are:
Central Valley Community Foundation (California)
$65.1 million for the F3 – Fresno-Merced Future of Food
City of Manchester (New Hampshire)
$44 million for The BioFabrication Cluster
Coalfield Development (West Virginia)
$62.8 million for the Appalachian Climate Technologies (ACT Now) Initiative
Detroit Regional Partnership Foundation (Michigan)
$52.2 million for the Global Epicenter of Mobility
Empire State Development (New York)
$25 million for the Western New York’s Advanced Manufacturing Cluster
Four Bands Community Fund (South Dakota)
$45 million for the Mountain | Plains Regional Native CDFI Coalition
Georgia Tech Research Corporations (Georgia)
$65 million for GA-AIM
Greater New Orleans Development Foundation (Louisiana)
$50 million for H2theFuture
Greater St. Louis Inc. (Missouri)
$25 million for the St. Louis Tech Triangle
Indian Nations Council of Governments (Oklahoma)
$39 million for the Tulsa Regional Advanced Mobility Cluster
Invest Nebraska Corporation (Nebraska)
$25 million for the Heartland Robotics Cluster
North Carolina Biotechnology Center (North Carolina)
$25 million for Accelerate NC – Life Sciences Manufacturing
Oklahoma City Economic Development Foundation (Oklahoma)
$35 million for the Oklahoma Biotech Innovation Cluster Initiative
Osceola County Board of County Commissioners (Florida)
$50.8 million for the Building Central Florida’s Semiconductor Cluster for Broad-Based Prosperity
Port of Portland (Oregon)
$41.4 million for the Oregon Mass Timber Coalition
Southeast Conference (Alaska)
$49 million for the Alaska Mariculture Cluster
Southwestern Pennsylvania New Economy Collaborative (Pennsylvania)
$62.7 million for the Southwestern Pennsylvania New Economy Collaborative
The State University of New York (SUNY) at Binghamton (New York)
$63.7 million for New Energy New York
The University of Texas at El Paso (Texas)
$40 million for the West Texas A&D Cluster
Wichita State University (Kansas)
$51.4 million for the South Kansas Coalition
Click here to read Pharma Commerce's recent interview with Chandra Briggman, President and CEO of Richmond's Activation Capital.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.